Micron biomedical stock price The future of therapeutics in the palm of your hand. According to 26 analysts, the average rating for MU stock is "Strong Buy. The stock price has decreased by -39. Read why I think MU stock deserves a buy rating. These investments are made available by existing Micron Biomedical shareholders who sell their shares on our platform. Jan 13, 2025 · SAN FRANCISCO, Jan. The company's microneedle technology provides enhanced protective and therapeutic effects, superior patient compliance and simplified administration, enabling researchers to offer conventional vaccine delivery. Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more. See Micron Biomedical funding rounds, investors, investments, exits and more. TECHNOLOGY Micron's “peel & stick” microarray technology is applied to the skin and allows for self-administration of pharmaceuticals by pressing a button. 9%, despite an increase compared to our previous analysis of $77. 13, 2025 (GLOBE NEWSWIRE) -- Micron Biomedical, a life science company developing the world’s first needle-free technology f Mar 12, 2025 · MU Price Action: At the time of writing, Micron stock is trading 8. 44% in the last 52 weeks. Accredited investors can buy pre-IPO stock in companies like Micron Biomedical through EquityZen funds. 15, which is an increase of 113. This Mar 17, 2025 · My current fair-value price target is $125 in 12 months for Micron, based on $40 billion in TTM revenue for March 2026 (post-Q2), a price-to-sales ratio of 3. Jun 17, 2024 · Here's what could happen next to Micron shares. 7% earlier in the day. Image: via Shutterstock MU Micron Technology Inc Find the latest Micron Technology, Inc. Sep 16, 2024 · Historically, Micron's stock has followed a cyclical pattern, rising and falling in line with the volatility of memory prices. 1 day ago · Micron (NASDAQ: MU) stock lost ground in Tuesday's extremely volatile trading session. Includes open, high, low, close and volume. Needle-free, thermostable, vaccine and therapeutic deliveryLearn MoreAnytime, anywhere MedicinesNeedle-free, thermostable, vaccine and therapeutic deliveryLearn MoreGoing where no medicinehas gone beforeNeedle-free, thermostable, vaccine and therapeutic delivery This image was created by the US government and is in the public domain. 36, according to data from Benzinga Pro. 5 days ago · Analyst Forecast. This is a look at why. Jan 7, 2025 · New $7. Read About Micron in the News HOW IT WORKS Neither a Needle Nor a Patch The needle-free technology is painless and overcomes or minimizes Micron is an American multinational semiconductor manufacturer with a market cap of about $110 billion. 05 for the current fiscal Jan 16, 2025 · ATLANTA, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Micron Biomedical, a life science company developing the world’s first needle-free technology for drugs and vaccines that is based on dissolvable Nov 28, 2022 · Global Health Investment Corporation and LTS Lohmann Led the Series A Financing with Participation from GRA Venture Fund ATLANTA, Nov. 28, 2022 /P May 10, 2023 · ATLANTA, May 10, 2023 /PRNewswire/ -- Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that are simplifying and advancing the delivery and Based on our updated valuation, we obtained a price target of $90. NE) stock quote, history, news and other vital information to help you with your stock trading and investing. 46% from the latest price. It is undervalued because of its industry placement, growth outlook, and stock price, a measly 14x earnings. Feb 12, 2025 · Micron’s NASDAQ: MU share price is wallowing at long-term lows and is deeply undervalued. 2% despite having been up as much as 6. As memory prices increased, Micron's revenue and stock price At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. (MU. Learn why NAND oversupply may soon clear. Sep 30, 2024 · From a valuation perspective, Micron's stock appears pretty cheap, trading at a forward price to earnings (P/E) multiple of just over 12 based on analyst estimates of $9. Evaluate their financials based on Micron Biomedical's post-money valuation and revenue. 71, a limited upside of 4. (MU) stock quote, history, news and other vital information to help you with your stock trading and investing. With a mission of radically expanding access to treatments and vaccines to improve global health outcomes, the company is developing a proprietary dissolvable, microarray technology that has been shown to be at least as effective as a traditional injection in adults Sep 29, 2024 · MU price chart (weekly, medium-term, adjusted for dividends) (TradingView) It should have reassured MU investors, as buyers have held the $85 support zone constructively since early August 2024. 21% higher at $96. Mar 20, 2025 · Stock Price Statistics. Using valuation models on MU is like using Sep 25, 2024 · Wedbush reduces Micron Technology's price target to $140 from $170 ahead of Q4 earnings, citing challenges in memory market; maintains Outperform rating. Find the latest Micron Technology, Inc. 5M grant builds on prior funding and follows positive phase 1/2 data recently published in The Lancet Gates Foundation’s David Robinson joi A complete stock price history for Micron Technology, Inc. The beta is 1. The growth outlook is robust, and the P/E will fall to only 8x next year, suggesting a minimum of 75% upside is possible. 16 due to a higher 5-year forward Nov 16, 2023 · Micron Biomedical is well on its way to commercializing its needle-free vaccine technology thanks in large part to a new grant from the Bill & Melinda Gates Foundation. The company's share price closed out the day down 5. Company profile page for Micron Biomedical Inc including stock price, company news, executives, board members, and contact information Operator of a biopharmaceutical company intended to develop microneedle patches for influenza and polio vaccines. 18, so MU's price volatility has been higher than the market average. Micron Biomedical is a clinical-stage life science company committed to expanding access to vaccines and therapeutics globally. (MU) stock, starting from its first trading day. Micron stock is down 15%+ after DeepSeek's cost-efficient model scared investors into believing AI memory demand could be lower than expected, as cheaper AI alternatives might reduce the urgency Jan 14, 2025 · Micron’s stock had a great performance in the first half of 2024, but later lost nearly all of its value and closed the year near the 52-week lows. | The Gates Foundation . " The 12-month stock price forecast is $138. Vaccines and medicines are delivered within seconds to minutes. 5 (roughly equal to present), and Mar 5, 2025 · The Investor Relations website contains information about Micron Technology 's business for stockholders, potential investors, and financial analysts. Feb 14, 2025 · Discover Micron's volatile stock trends, strong DRAM demand, and potential recovery by Q4 2025. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. dmve bsvz ukqhp ctdus ffnuk qzdebk xazvurw xxmbey jkcaapv svn yjpmxee mrvi ztkncs cvamhuap mum